MARKET WIRE NEWS
  1. Home
  2. Stock
  3. NGNE
  4. News
NGNE
Quote
Short
News
Articles
Message Board

Neurogene Inc. (NASDAQ : NGNE ) News

Neurogene Inc. (NASDAQ: NGNE) News Releases

NGNE News Releases
NGNE : NASDAQ
Business Wire
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
NGNE : NASDAQ
Business Wire
Neurogene Appoints Christy Shafer as Chief Commercial Officer and Christine Mikail, J.D., to Board of Directors
NGNE : NASDAQ
Zolmax
Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
NGNE : NASDAQ
SeekingAlpha
Neurogene GAAP EPS of -$4.24 beats by $0.04
NGNE : NASDAQ
Business Wire
Neurogene Reports Full Year 2025 Financial Results and Highlights Recent Updates
NGNE : NASDAQ
Business Wire
Neurogene to Participate in Stifel 2026 Virtual CNS Forum
NGNE : NASDAQ
SeekingAlpha
Neurogene: Stock Soars On FDA Designation For Rett Gene Therapy - I'd Remain Cautious
NGNE : NASDAQ
PRISM News
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NGNE : NASDAQ
Business Wire
Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
NGNE : NASDAQ
Business Wire
Neurogene Announces Recent Achievements and Anticipated 2026 Key Milestones for NGN-401, a Potential Best-in-Class Gene Therapy for Rett Syndrome
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.